Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Donato, Barbato"'
Autor:
Khadija Benali, Liliane Louedec, Rana Ben Azzouna, Olivier Merceron, Pierre Nassar, Faisal Al Shoukr, Anne Petiet, Donato Barbato, Jean-Baptiste Michel, Laure Sarda-Mantel, Dominique Le Guludec, Francois Rouzet
Publikováno v:
Molecular Imaging, Vol 14 (2015)
Hydrazinonicotinamide–annexin A5 (HYNIC-Anx), a 99m technetium ( 99m Tc)-labeled agent targeting phosphatidylserine, proved to be sensitive for the detection of apoptosis and thrombosis but is no longer available for clinical use. A mutant of human
Externí odkaz:
https://doaj.org/article/0fd1db2324bc45ed870166983e9481ec
Autor:
Aikaterini Kaloudi, Emmanouil Lymperis, Athina Giarika, Simone Dalm, Francesca Orlandi, Donato Barbato, Mattia Tedesco, Theodosia Maina, Marion de Jong, Berthold A. Nock
Publikováno v:
Molecules, Vol 22, Iss 11, p 1950 (2017)
Background: The GRPR-antagonist-based radioligands [67/68Ga/111In/177Lu]NeoBOMB1 have shown excellent theragnostic profiles in preclinical prostate cancer models, while [68Ga]NeoBOMB1 effectively visualized prostate cancer lesions in patients. We wer
Externí odkaz:
https://doaj.org/article/2fd91a26029645ea860c5bc702710e95
Autor:
Christopher, Montemagno, Florian, Raes, Mitra, Ahmadi, Sandrine, Bacot, Marlène, Debiossat, Julien, Leenhardt, Jean, Boutonnat, Francesca, Orlandi, Donato, Barbato, Mattia, Tedesco, Catherine, Ghezzi, Pascale, Perret, Alexis, Broisat
Publikováno v:
Cancers
Cancers, Vol 13, Iss 1051, p 1051 (2021)
Volume 13
Issue 5
Cancers, Vol 13, Iss 1051, p 1051 (2021)
Volume 13
Issue 5
NeoB is a radiotracer targeting the gastrin-releasing peptide receptor (GRPR), a G-protein–coupled receptor expressed in various cancers. The aim of the present study was to evaluate the biodistribution and efficacy of this new therapeutic agent in
Autor:
Salvatore Crisafulli, Valentina Ientile, Luca L’Abbate, Andrea Fontana, Claudio Linguiti, Sonia Manna, Mariangela Mercaldo, Claudia Pagliaro, Michele Vezzaro, Katia Santacà, Riccardo Lora, Ugo Moretti, Chiara Reno, Maria Pia Fantini, Salvatore Corrao, Donato Barbato, Michele Tari, Gianluca Trifirò, the ITA-COVID: COV-OUT Group
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 1; Pages: 51
Journal of Clinical Medicine, Vol 11, Iss 51, p 51 (2022)
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 11, Iss 51, p 51 (2022)
Journal of Clinical Medicine
Evidence on treatments for early-stage COVID-19 in outpatient setting is sparse. We explored the pattern of use of drugs prescribed for COVID-19 outpatients’ management in Southern Italy in the period February 2020–January 2021. This population-b
Autor:
Erik de Blois, Donato Barbato, Mark Konijnenberg, Mattia Tedesco, Berthold A. Nock, Gabriela N. Doeswijk, Francesca Orlandi, Theodosia Maina, Marion de Jong, Simone U. Dalm, Ingrid L. Bakker
Publikováno v:
Journal of Nuclear Medicine, 58(2), 293-299. Society of Nuclear Medicine and Molecular Imaging
Because overexpression of the gastrin-releasing peptide receptor (GRPR) has been reported on various cancer types, for example, prostate cancer and breast cancer, targeting this receptor with radioligands might have a significant impact on staging an
Autor:
Donato Barbato, Berthold A. Nock, Theodosia Maina, Athina Giarika, Simone U. Dalm, Marion de Jong, Emmanouil Lymperis, Aikaterini Kaloudi, Francesca Orlandi, Mattia Tedesco
Publikováno v:
Molecules; Volume 22; Issue 11; Pages: 1950
Molecules, 22(11):1950. Multidisciplinary Digital Publishing Institute (MDPI)
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules, Vol 22, Iss 11, p 1950 (2017)
Molecules, 22(11):1950. Multidisciplinary Digital Publishing Institute (MDPI)
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules, Vol 22, Iss 11, p 1950 (2017)
Background: The GRPR-antagonist-based radioligands [67/68Ga/111In/177Lu]NeoBOMB1 have shown excellent theragnostic profiles in preclinical prostate cancer models, while [68Ga]NeoBOMB1 effectively visualized prostate cancer lesions in patients. We wer
Autor:
Khadija Benali, Laure Sarda-Mantel, Anne Petiet, Dominique Le Guludec, Olivier Merceron, Liliane Louedec, François Rouzet, Pierre Nassar, Jean-Baptiste Michel, Faisal Al Shoukr, Donato Barbato, Rana Ben Azzouna
Publikováno v:
Molecular imaging. 13
Hydrazinonicotinamide–annexin A5 (HYNIC-Anx), a 99m technetium ( 99m Tc)-labeled agent targeting phosphatidylserine, proved to be sensitive for the detection of apoptosis and thrombosis but is no longer available for clinical use. A mutant of human